By inhibiting the PI3K/AKT/mTOR signaling pathway, they not only impede the progression of hepatocellular carcinoma but also concurrently modulate abnormal lipid metabolism and fibrosis development. The gene discussed is MTOR; the disease is hepatocellular carcinoma.